What's new?

 

Welcome to
US Medical Affairs

Chronic Kidney Disease

Welcome to Bayer's Medical Affairs Chronic Kidney Disease (CKD) platform.

 

CKD is one of the most frequent complications arising from diabetes and is an independent risk factor of cardiovascular disease. CKD associated with type 2 diabetes (T2D) is the most common cause of kidney failure worldwide.

 

With early intervention being associated with a better prognosis for these patients, at Bayer, we are committed to advancing awareness, knowledge, and therapeutic options for CKD associated with T2D. We invite you to explore educational resources and information on this website.

Recent Updates

June 2024

Podcast Series: Expert Clinician Conversations

Take me there!

June 2024

Albuminuria: Connection to CV Outcomes and More

Take me there!

May 2024

NKF Congress Presentations

Take me there!

May 2024

ESC-HF Congress Presentations

Take me there!

April 2024

Publications Library Enhancements

Take me there!

June 2024

Podcast Series: Expert Clinician Conversations

June 2024

Albuminuria: Connection to CV Outcomes and More

May 2024

NKF Congress Presentations

May 2024

ESC-HF Congress Presentations

April 2024

Publications Library Enhancements